Merck Agrees To Audits As Part Of Cozaar Campaign Remediation
This article was originally published in The Pink Sheet Daily
The company, which has been suspended from the Association of the British Pharmaceutical Industry for the violations, will send corrective letters to physicians solicited as part of the campaign.
You may also be interested in...
The company gains exclusive rights to NicOx’ nitric oxide-donating technology for use with systemic hypertension treatments.
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4